This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacoby, G. A.
Right arrow Articles by Chow, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacoby, G. A.
Right arrow Articles by Chow, N.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2004, p. 3203-3206, Vol. 48, No. 8
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.8.3203-3206.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Role of ß-Lactamases and Porins in Resistance to Ertapenem and Other ß-Lactams in Klebsiella pneumoniae

George A. Jacoby,* Debra M. Mills, and Nancy Chow

Lahey Clinic, Burlington, Massachusetts

Received 23 January 2004/ Returned for modification 6 March 2004/ Accepted 22 April 2004

High-level resistance to ertapenem was produced by ß-lactamases of groups 1, 2f, and 3 in a strain of Klebsiella pneumoniae deficient in Omp35 and Omp36. From a wild-type strain producing ACT-1 ß-lactamase, ertapenem-resistant mutants for which the ertapenem MICs were up to 128 µg/ml and expression of outer membrane proteins was diminished could be selected.


* Corresponding author. Mailing address: Lahey Clinic, 41 Mall Rd., Burlington, MA 01805. Phone: (781) 744-2928. Fax: (781) 744-5486. E-mail: george.a.jacoby{at}lahey.org.


Antimicrobial Agents and Chemotherapy, August 2004, p. 3203-3206, Vol. 48, No. 8
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.8.3203-3206.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Schneider, I., Queenan, A. M., Markovska, R., Markova, B., Keuleyan, E., Bauernfeind, A. (2009). New Variant of CTX-M-Type Extended-Spectrum {beta}-Lactamases, CTX-M-71, with a Gly238Cys Substitution in a Klebsiella pneumoniae Isolate from Bulgaria. Antimicrob. Agents Chemother. 53: 4518-4521 [Abstract] [Full Text]  
  • Landman, D., Bratu, S., Quale, J. (2009). Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J Med Microbiol 58: 1303-1308 [Abstract] [Full Text]  
  • Wang, X. D., Cai, J. C., Zhou, H. W., Zhang, R., Chen, G.-X. (2009). Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated {beta}-lactamase production and OmpK36 porin deficiency. J Med Microbiol 58: 1196-1202 [Abstract] [Full Text]  
  • Grobner, S., Linke, D., Schutz, W., Fladerer, C., Madlung, J., Autenrieth, I. B., Witte, W., Pfeifer, Y. (2009). Emergence of carbapenem-non-susceptible extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J Med Microbiol 58: 912-922 [Abstract] [Full Text]  
  • Leavitt, A., Chmelnitsky, I., Colodner, R., Ofek, I., Carmeli, Y., Navon-Venezia, S. (2009). Ertapenem Resistance among Extended-Spectrum-{beta}-Lactamase-Producing Klebsiella pneumoniae Isolates. J. Clin. Microbiol. 47: 969-974 [Abstract] [Full Text]  
  • Doumith, M., Ellington, M. J., Livermore, D. M., Woodford, N. (2009). Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63: 659-667 [Abstract] [Full Text]  
  • Girlich, D., Poirel, L., Nordmann, P. (2009). CTX-M Expression and Selection of Ertapenem Resistance in Klebsiella pneumoniae and Escherichia coli. Antimicrob. Agents Chemother. 53: 832-834 [Abstract] [Full Text]  
  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  
  • Girlich, D., Poirel, L., Nordmann, P. (2008). Do CTX-M {beta}-lactamases hydrolyse ertapenem?. J Antimicrob Chemother 62: 1155-1156 [Full Text]  
  • Cai, J. C., Zhou, H. W., Zhang, R., Chen, G.-X. (2008). Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates Possessing the Plasmid-Mediated Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 in Intensive Care Units of a Chinese Hospital. Antimicrob. Agents Chemother. 52: 2014-2018 [Abstract] [Full Text]  
  • Rodloff, A. C., Goldstein, E. J. C., Torres, A. (2006). Two decades of imipenem therapy. J Antimicrob Chemother 58: 916-929 [Abstract] [Full Text]  
  • Kaczmarek, F. M., Dib-Hajj, F., Shang, W., Gootz, T. D. (2006). High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of blaACT-1 {beta}-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE.. Antimicrob. Agents Chemother. 50: 3396-3406 [Abstract] [Full Text]  
  • Navon-Venezia, S., Chmelnitsky, I., Leavitt, A., Schwaber, M. J., Schwartz, D., Carmeli, Y. (2006). Plasmid-Mediated Imipenem-Hydrolyzing Enzyme KPC-2 among Multiple Carbapenem-Resistant Escherichia coli Clones in Israel.. Antimicrob. Agents Chemother. 50: 3098-3101 [Abstract] [Full Text]  
  • Szabo, D., Silveira, F., Hujer, A. M., Bonomo, R. A., Hujer, K. M., Marsh, J. W., Bethel, C. R., Doi, Y., Deeley, K., Paterson, D. L. (2006). Outer Membrane Protein Changes and Efflux Pump Expression Together May Confer Resistance to Ertapenem in Enterobacter cloacae.. Antimicrob. Agents Chemother. 50: 2833-2835 [Abstract] [Full Text]  
  • Mena, A., Plasencia, V., Garcia, L., Hidalgo, O., Ayestaran, J. I., Alberti, S., Borrell, N., Perez, J. L., Oliver, A. (2006). Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance Development.. J. Clin. Microbiol. 44: 2831-2837 [Abstract] [Full Text]  
  • Samuel, J. R., Natarajan, M., Rizkalla, E., Livermore, D. M., Warner, M., Jenkinson, P. (2005). Disagreements between disc diffusion, and MIC-based susceptibility categorizations of ertapenem versus ESBL producers. J Antimicrob Chemother 56: 984-985 [Full Text]